Skip to main content
. 2022 Feb 23;12:3076. doi: 10.1038/s41598-022-06758-8

Table 1.

Demographic, anthropometric, medication history and biochemical variables in CAD cases and healthy controls.

Parameters CAD Cases (n = 53) Controls (n = 42) p value
Age (years) 52.70 ± 5.4 49.00 ± 6.3 0.003
BMI (Kg/m2) 23.70 ± 4.1 26.07 ± 3.4 0.004
Gender (n %) M (44; 83.0%) F (09; 16.9%) M (34; 80.9%) F (8; 19.0%) 0.794
Family history
CVD (n %) 11; 20.75% 06; 14.29% 0.414
Diabetes (n%) 19; 35.85% 08; 19.00% 0.071
Hypertension (n %) 30; 56.00% 5; 11.90%  < 0.0001
Dyslipidemia (n %) 02; 3.70% 07; 16.60% 0.033
Lifestyle factors
Smoking (n %) 18; 33.96% 08; 19.0% 0.105
Alcohol (n %) 13; 24.53% 08; 19.0% 0.523
Medication history
ACE Inhibitor (n %) 23 (43.4%) Nil
β-Blocker (n %) 45 (84.9%) Nil
Statin (n %) 46 (86.7%) Nil
Aspirin (n %) 47 (88.6%) Nil
Ca2 + Channel Blocker (n %) 08 (15.0%) Nil
Diuretics (n %) 10 (18.8%) Nil
Nitrate (n %) 38 (71.7%) Nil
Baseline biochemical parameters
Fasting Blood Glucose (mg/dl) 111 (104—123) 105 (96—121) 0.084
Total Cholesterol (TC) (mg/dl) 126.0 ± 36.1 186.8 ± 49.3  < 0.0001
Triglyceride (mg/dl) 98.0 (65—133) 157.5 (121—213)  < 0.0001
HDL cholesterol (mg/dl) 36.0 ± 9.4 41.7 ± 9.0 0.003
LDL cholesterol (mg/dl) 76.1 ± 27.2 113.6 ± 32.6  < 0.0001
VLDL cholesterol (mg/dl) 12.0 (9.0 – 16.0) 24.6 (16.8 – 39.0)  < 0.0001
TC: HDL 3.56 ± 0.82 4.48 ± 0.84  < 0.0001
LDL: HDL 2.15 ± 0.68 2.72 ± 0.59  < 0.0001
Creatinine (mg/dl) 0.74 ± 0.18 0.71 ± 0.15 0.464

Data expressed as mean ± standard deviation for normally distributed data and as median and interquartile range (IQR) for non-normally distributed data. Categorical variables were represented in percentage. Unpaired t-test and Mann Whitney test U was performed for normally and non-normally distributed data and Chi2 test for categorical variables respectively. p values ≤ 0.05 was considered statistically significant.